MedPath

Hydrocortisone

Hydrocortisone Tablets, USP

Approved
Approval ID

5b707a9f-32b6-42f3-beb6-111df98dfde5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 18, 2023

Manufacturers
FDA

Chartwell RX, LLC

DUNS: 079394054

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrocortisone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62135-186
Application NumberANDA085070
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydrocortisone
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 18, 2023
FDA Product Classification

INGREDIENTS (5)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
HYDROCORTISONEActive
Quantity: 20 mg in 1 1
Code: WI4X0X7BPJ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydrocortisone - FDA Drug Approval Details